Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Identification of morpholine based hydroxylamine analogues: selective inhibitors of MARK4/Par-1d causing cancer cell death through apoptosis
Mudasir Nabi Peerzada, Parvez Κhan, Nashrah Sharif Khan, et al.
New Journal of Chemistry (2020) Vol. 44, Iss. 38, pp. 16626-16637
Closed Access | Times Cited: 16

Showing 16 citing articles:

Deciphering the key heterocyclic scaffolds in targeting microtubules, kinases and carbonic anhydrases for cancer drug development
Mudasir Nabi Peerzada, Ernest Hamel, Ruoli Bai, et al.
Pharmacology & Therapeutics (2021) Vol. 225, pp. 107860-107860
Closed Access | Times Cited: 53
Investigating MARK4 inhibitory potential of Bacopaside II: Targeting Alzheimer's disease
Saleha Anwar, Taj Mohammad, Md. Khabeer Azhar, et al.
International Journal of Biological Macromolecules (2023) Vol. 245, pp. 125364-125364
Closed Access | Times Cited: 16
Microtubule-affinity regulating kinase 4: A potential drug target for cancer therapy
Saleha Anwar, Moyad Shahwan, Gulam Mustafa Hasan, et al.
Cellular Signalling (2022) Vol. 99, pp. 110434-110434
Closed Access | Times Cited: 18
Discovery of Novel Hydroxyimine-Tethered Benzenesulfonamides as Potential Human Carbonic Anhydrase IX/XII Inhibitors
Mudasir Nabi Peerzada, Daniela Vullo, Niccolò Paoletti, et al.
ACS Medicinal Chemistry Letters (2023) Vol. 14, Iss. 6, pp. 810-819
Open Access | Times Cited: 10
A Network-Guided Approach to Discover Phytochemical-Based Anticancer Therapy: Targeting MARK4 for Hepatocellular Carcinoma
Sarfraz Ahmed, Mohammad Mobashir, Lamya Ahmed Al‐Keridis, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 17
Targeting inhibition of microtubule affinity regulating kinase 4 by Harmaline: Strategy to combat Alzheimer's disease
Mohd Adnan, Saleha Anwar, Debarati DasGupta, et al.
International Journal of Biological Macromolecules (2022) Vol. 224, pp. 188-195
Closed Access | Times Cited: 16
Therapeutic targeting of microtubule affinity‐regulating kinase 4 in cancer and neurodegenerative diseases
Manzar Alam, Sarfraz Ahmed, Mohammad Abid, et al.
Journal of Cellular Biochemistry (2023) Vol. 124, Iss. 9, pp. 1223-1240
Open Access | Times Cited: 9
Inhibition of Microtubule Dynamics in Cancer Cells by Indole-Modified Latonduine Derivatives and Their Metal Complexes
Christopher Wittmann, Anastasiia S. Sivchenko, Felix Bacher, et al.
Inorganic Chemistry (2022) Vol. 61, Iss. 3, pp. 1456-1470
Open Access | Times Cited: 15
Design, synthesis, molecular docking and anti-proliferative activity of novel phenothiazine containing imidazo[1,2-a]pyridine derivatives against MARK4 protein
Avijit Bhakta, Sayeed Mukhtar, Saleha Anwar, et al.
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 6, pp. 1942-1958
Closed Access | Times Cited: 2
Recent drug design strategies and identification of key heterocyclic scaffolds for promising anticancer targets
Alia Mushtaq, Peng Wu, Muhammad Moazzam Naseer
Pharmacology & Therapeutics (2023) Vol. 254, pp. 108579-108579
Closed Access | Times Cited: 7
Machine learning and graph neural network for finding potential drugs related to multiple myeloma
Haohuai He, Guanxing Chen, Calvin Yu‐Chian Chen
New Journal of Chemistry (2022) Vol. 46, Iss. 11, pp. 5188-5200
Closed Access | Times Cited: 4
Naturbasierte bioinformatische Ansätze in der Arzneimittelforschung gegen vielversprechende molekulare Ziele – Carbonanhydrasen und Serin/Threonin-Kinasen zur Krebsbehandlung
Mudasir Nabi Peerzada, Masood Ahmad Rizvi, K.K. Ajeeshkumar, et al.
(2024), pp. 343-363
Closed Access
Privileged Scaffolds in Drug Discovery against Human Epidermal Growth Factor Receptor 2 for Cancer Treatment
Mudasir Nabi Peerzada, Rania Hamdy, Masood Ahmad Rizvi, et al.
Current Pharmaceutical Design (2023) Vol. 29, Iss. 44, pp. 3563-3578
Closed Access | Times Cited: 1
Microtubule affinity regulating kinase 4: A potential drug target from cancers to neurodegenerative diseases
Narendran Annadurai, Viswanath Das
Elsevier eBooks (2022), pp. 571-596
Closed Access | Times Cited: 2
Nature-Based Computing Bioinformatics Approaches in Drug Discovery Against Promising Molecular Targets Carbonic Anhydrases and Serine/Threonine Kinases for Cancer Treatment
Mudasir Nabi Peerzada, Masood Ahmad Rizvi, Ajeesh Kumar KK, et al.
Studies in computational intelligence (2022), pp. 309-328
Closed Access | Times Cited: 2
Discovery of medicinal herbal compounds with potential anti-cancer activities against microtubule affinity-regulating kinase (MARK4) in cancer therapy
Nayana Narayanan, Sivakumar Krishnankutty Chandrika
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Page 1

Scroll to top